XBI241108P94500
- 0.34
- +0.01+3.03%
SPDR S&P Biotech ETF Newsroom
We Want YOU to Submit Questions for Election Night
Market Climbs for Election Day Excitement | Live Stock
Here Are the Major Earnings After the Close Today
Arcellx Issues Updates on Anito-cel Clinical Trials
Gilead's Kite To Highlight CAR T-Cell Therapy Portfolio At ASH 2024, Including Survival Outcomes In Both Clinical Trials And The Real-World
Viking Therapeutics Analyst Ratings
How Is The Market Feeling About Natera?
Exact Sciences Q3 2024 Earnings Preview
US stocks closed: Trump, Harris concept stocks rose together, Chinese concept stocks remained stable and rose.
1. The market is filled with a wait-and-see attitude, with all three major indexes collectively falling. 2. Trump's media technology group rebounded after hitting bottom. 3. Photovoltaic and clean energy concept stocks strengthened collectively. 4. Reports claim that Nvidia will distribute Super Micro Computer orders to other suppliers.
Syndax, Royalty Pharma Enter Into $350M Royalty Funding Deal
Monday Market Moves Sideways, Election and FOMC in Sight | Wall Street Today
How Does Viking's Weight Loss Med Compare to Ones From Novo, Eli Lilly?
Mid-cap Stocks With 'Significant Scope' to Upside – WF
Viking Therapeutics Shares Are Trading Lower. The Company Revealed Weight Loss Results From Its Oral Obesity Drug FK2735 at ObesityWeek 2024.
8 High-momentum Stocks Set for Success – Oppenheimer
Here's How Much $100 Invested In AbbVie 10 Years Ago Would Be Worth Today
Monday Market Mixed Before Crazy, Pivotal Week | Live Stock
AbbVie Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target
Viking Shares Jump After Positive Early Data on Oral Obesity Pill; Lilly, Novo Drop